Immediate Impact
1 standout
Citing Papers
Bispecific Antibodies: From Research to Clinical Application
2021 Standout
Works of Daniela V. Wenge being referenced
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela V. Wenge | 36 | 34 | 5 | 13 | 11 | 52 | |
| Valentine Richez | 30 | 20 | 5 | 12 | 8 | 37 | |
| Claudia Saitta | 33 | 40 | 9 | 4 | 8 | 67 | |
| Émilie Lemasle | 52 | 26 | 17 | 8 | 9 | 60 | |
| Ana Gorosquieta | 21 | 27 | 10 | 7 | 9 | 56 | |
| Caroline Barbieri Blunck | 34 | 21 | 5 | 13 | 10 | 72 | |
| Gudrun Goehring | 32 | 19 | 10 | 4 | 7 | 39 | |
| R Mataix | 24 | 7 | 8 | 9 | 8 | 33 | |
| Kimo Bachiashvili | 24 | 17 | 7 | 10 | 17 | 42 | |
| Titouan Cazaubiel | 47 | 37 | 8 | 31 | 11 | 60 | |
| Ricardo Delumpa | 64 | 32 | 25 | 5 | 8 | 71 |
All Works
Login with ORCID to disown or claim papers
Loading papers...